Skip to main content
Medinice S.A. logo

Medinice S.A. — Investor Relations & Filings

Ticker · ICE ISIN · PLMDNCE00016 LEI · 259400LGO9UDV1Y18Z11 WAR Manufacturing
Open in API
Filings indexed 771 across all filing types
Latest filing 2021-04-20 Report Publication Anno…
Country PL Poland
Listing WAR ICE

About Medinice S.A.

https://www.medinice.pl/?lang=2

Medinice S.A. is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions in the fields of cardiology and cardiac surgery. The company's mission is to create patient-focused technologies that improve the quality of life for individuals with cardiac diseases. Its portfolio consists of advanced medical devices, including Class III devices, which undergo a full research, development, and clinical trial process before market introduction. Key projects include CoolCryo, a cryoablation system; AtriClamp, for left atrial appendage closure; and PacePress, a specialized compression band used after cardiac device implantation procedures.

Recent filings

Filing Released Lang Actions
List Prezesa Zarządu GK Medinice S.A.
Report Publication Announcement Classification · 95% confidence The document is a 'Letter from the CEO' (List Prezesa Zarządu) which serves as an introduction to the Consolidated Annual Report for 2020. It summarizes the company's activities, R&D progress, and financial outlook for the year. While it references the 'Consolidated Annual Report' (Skonsolidowany Raport Roczny), the document itself is a narrative letter/preface rather than the full financial statements or the complete 10-K filing. According to the 'Menu vs Meal' rule, this is an announcement or introductory material accompanying the report, and since it does not contain the full financial statements, it is best classified as a Report Publication Announcement (RPA). FY 2020
2021-04-20 Polish
Projekty Uchwał
AGM Information Classification · 99% confidence The document contains resolutions ('Uchwała') from an Extraordinary General Meeting ('Nadzwyczajnego Walnego Zgromadzenia') of Medinice S.A. dated May 6, 2021. The resolutions cover procedural matters (electing a chairman, adopting the agenda) and substantive decisions, most notably Resolution No. 3, which concerns raising the share capital ('podwyższenia kapitału zakładowego') through the issuance of new Series J shares, excluding pre-emptive rights ('wyłączeniem w całości prawa poboru'), and amending the company's Articles of Association ('zmiany Statutu Spółki'). It also includes the required Management Board Opinion justifying the exclusion of pre-emptive rights. Documents detailing decisions made and voted upon at a General Meeting, especially those concerning capital structure changes and voting results, fall under the scope of AGM-related materials. Since the document details the resolutions passed at the meeting itself, and not just the announcement of voting results (DVA) or a proxy statement (PSI), the most appropriate classification is AGM-R (AGM Information/Resolutions).
2021-04-09 Polish
Projekty uchwał na Nadzwyczajne Walne Zgromadzenie spółki Medinice S.A. zwołane na dzień 6 maja 2021 r. - Content (PL)
AGM Information Classification · 96% confidence The document text is very short (926 characters) and explicitly states that the Management Board of Medinice S.A. is providing the content of draft resolutions ('treść projektów uchwał') that will be the subject of an Extraordinary General Meeting ('Nadzwyczajnego Walnego Zgromadzenia') scheduled for May 6, 2021, with the resolutions attached ('projekty uchwał w załączniku'). This structure—announcing the agenda/proposals for a shareholder meeting—is characteristic of materials related to a General Meeting. Since it is announcing the proposals for a meeting, it is closely related to AGM information, but the specific content is the draft resolutions themselves, which are often distributed prior to the meeting. Given the options, 'AGM-R' (AGM Information) is the most appropriate fit as it covers materials shared during the AGM, and pre-meeting proposals are core materials. The 'MENU VS MEAL' rule suggests that if this were just an announcement *about* the meeting date, RPA might apply, but since it contains the actual draft resolutions for the meeting, AGM-R is better than RPA or RNS.
2021-04-09 Polish
Ogłoszenie o zwołaniu NWZ
AGM Information Classification · 100% confidence The document text is a formal announcement by Medinice S.A. detailing the convocation (zwołanie) of an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie Spółki - NWZ) scheduled for May 6, 2021. It outlines the agenda (Porządek obrad), which includes proposals for capital increase, dematerialization of shares, and amendments to the Articles of Association. Crucially, it details the procedures for shareholder participation, voting rights, and proxy appointments. This content—announcing a general meeting and providing procedural rules—is characteristic of a notice sent to shareholders to solicit their attendance and votes, which aligns directly with the definition of a Proxy Solicitation & Information Statement (PSI). It is not the minutes of the meeting (AGM-R), the full annual report (10-K), or just a dividend notice (DIV).
2021-04-09 Polish
Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia spółki Medinice S.A. na dzień 6 maja 2021 r. - Content (PL)
AGM Information Classification · 95% confidence The document text is in Polish and announces the convening of an Extraordinary General Meeting ('Nadzwyczajnego Walnego Zgromadzenia Spółki') scheduled for May 6, 2021. It cites Polish financial regulations regarding current and periodic information disclosure. The key phrase is the announcement of the meeting itself, which relates to shareholder meetings. This aligns best with the 'AGM Information' category, as an Extraordinary General Meeting (EGM) is a type of general meeting, even if it's not the Annual General Meeting (AGM). Since the document is short and announces the meeting details, it is the primary announcement material for that event.
2021-04-09 Polish
Otrzymanie ochrony patentowej od koreańskiego urzędu patentowego na wynalazek „Kaniula do małoinwazyjnej plastyki zastawki trójdzielnej” - Content (PL)
Regulatory Filings Classification · 100% confidence The document text is a short announcement (723 characters) from the Management Board (Zarząd) of Medinice S.A. stating that they have received notification of a patent grant from the Korean Intellectual Property Office for an invention related to a medical cannula. This is a specific announcement regarding intellectual property (patent) acquisition, which is a form of corporate development or legal/regulatory update. It is not a full financial report (10-K, IR), an earnings release (ER), or a management discussion (MDA). Since it concerns the granting of a patent, it falls under general corporate information that is often disclosed via regulatory channels. Given the options, 'Regulatory Filings' (RNS) is the most appropriate general category for miscellaneous, non-financial, specific corporate event disclosures that don't fit the other specialized codes (like DIRS, DIV, MANG). It is not a Legal Proceedings Report (LTR) as it is a positive IP development, not a lawsuit. It is not a Financing Update (CAP). Therefore, RNS is the best fit as a general regulatory disclosure.
2021-03-31 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.